Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58319818 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.54330172 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.54330172 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.02372542 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.02372542 |
6 | modulation by symbiont of host immune response (GO:0052553) | 4.02372542 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.02372542 |
8 | modulation by symbiont of host defense response (GO:0052031) | 4.02372542 |
9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.02372542 |
10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.97758209 |
11 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.86722916 |
12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.80168417 |
13 | oligosaccharide catabolic process (GO:0009313) | 3.74755291 |
14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.71327983 |
15 | immunoglobulin mediated immune response (GO:0016064) | 3.67959871 |
16 | glycosphingolipid catabolic process (GO:0046479) | 3.66694286 |
17 | DNA deamination (GO:0045006) | 3.53629035 |
18 | neutrophil activation involved in immune response (GO:0002283) | 3.52272676 |
19 | negative regulation of cell killing (GO:0031342) | 3.45637638 |
20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.45637638 |
21 | positive regulation of B cell differentiation (GO:0045579) | 3.41235218 |
22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39256131 |
23 | positive regulation of mast cell activation (GO:0033005) | 3.30281052 |
24 | regulation of mast cell degranulation (GO:0043304) | 3.29425391 |
25 | positive regulation of interferon-alpha production (GO:0032727) | 3.28814633 |
26 | glycolipid catabolic process (GO:0019377) | 3.24795741 |
27 | respiratory burst (GO:0045730) | 3.21532104 |
28 | response to peptidoglycan (GO:0032494) | 3.19738966 |
29 | macrophage activation involved in immune response (GO:0002281) | 3.19318059 |
30 | NIK/NF-kappaB signaling (GO:0038061) | 3.13583634 |
31 | amino sugar catabolic process (GO:0046348) | 3.12602668 |
32 | B cell mediated immunity (GO:0019724) | 3.11616217 |
33 | pinocytosis (GO:0006907) | 3.11472563 |
34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.11264777 |
35 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.10289640 |
36 | positive regulation of mast cell degranulation (GO:0043306) | 3.10289640 |
37 | regulation of interferon-alpha production (GO:0032647) | 3.09664491 |
38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.05139220 |
39 | ceramide catabolic process (GO:0046514) | 3.04939344 |
40 | pentose-phosphate shunt (GO:0006098) | 3.02835810 |
41 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02785181 |
42 | regulation of mast cell activation (GO:0033003) | 3.00426524 |
43 | negative regulation of granulocyte differentiation (GO:0030853) | 2.91099784 |
44 | N-acetylneuraminate metabolic process (GO:0006054) | 2.89918540 |
45 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89113792 |
46 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87700634 |
47 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.84891053 |
48 | mannose metabolic process (GO:0006013) | 2.83401094 |
49 | regulation of B cell differentiation (GO:0045577) | 2.82695560 |
50 | regulation of hypersensitivity (GO:0002883) | 2.79765858 |
51 | negative regulation of interleukin-12 production (GO:0032695) | 2.79375013 |
52 | regulation of superoxide anion generation (GO:0032928) | 2.79368535 |
53 | regulation of leukocyte degranulation (GO:0043300) | 2.78317676 |
54 | actin nucleation (GO:0045010) | 2.75961973 |
55 | negative regulation of phagocytosis (GO:0050765) | 2.71964698 |
56 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.71568541 |
57 | NADPH regeneration (GO:0006740) | 2.69009685 |
58 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66656293 |
59 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.66603288 |
60 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.66321833 |
61 | sphingolipid catabolic process (GO:0030149) | 2.66081725 |
62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.65909988 |
63 | response to interferon-beta (GO:0035456) | 2.63303466 |
64 | folic acid metabolic process (GO:0046655) | 2.62518706 |
65 | neutrophil mediated immunity (GO:0002446) | 2.62364793 |
66 | * lysosome organization (GO:0007040) | 2.60738160 |
67 | * lytic vacuole organization (GO:0080171) | 2.60738160 |
68 | regulation of cholesterol esterification (GO:0010872) | 2.60557589 |
69 | positive regulation of interferon-beta production (GO:0032728) | 2.58934064 |
70 | cholesterol efflux (GO:0033344) | 2.58435339 |
71 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.58132912 |
72 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.56084689 |
73 | low-density lipoprotein particle remodeling (GO:0034374) | 2.55259233 |
74 | membrane lipid catabolic process (GO:0046466) | 2.55068157 |
75 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.54372283 |
76 | response to fungus (GO:0009620) | 2.54249244 |
77 | phagosome maturation (GO:0090382) | 2.52827530 |
78 | germinal center formation (GO:0002467) | 2.51726670 |
79 | granulocyte activation (GO:0036230) | 2.51359150 |
80 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.51211781 |
81 | ribosomal small subunit assembly (GO:0000028) | 2.51104466 |
82 | regulation of gamma-delta T cell activation (GO:0046643) | 2.50516027 |
83 | regulation of macrophage chemotaxis (GO:0010758) | 2.49545454 |
84 | positive regulation of leukocyte degranulation (GO:0043302) | 2.49076635 |
85 | plasma lipoprotein particle clearance (GO:0034381) | 2.48015551 |
86 | negative regulation of interleukin-1 production (GO:0032692) | 2.47997258 |
87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.47050194 |
88 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.46485020 |
89 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.46485020 |
90 | positive regulation of antigen processing and presentation (GO:0002579) | 2.45389393 |
91 | DNA strand elongation (GO:0022616) | 2.45197722 |
92 | response to muramyl dipeptide (GO:0032495) | 2.44634351 |
93 | response to thyroid hormone (GO:0097066) | 2.42945185 |
94 | regulation of B cell apoptotic process (GO:0002902) | 2.42751312 |
95 | reactive oxygen species biosynthetic process (GO:1903409) | 2.41807928 |
96 | cellular response to interferon-beta (GO:0035458) | 2.41283681 |
97 | myeloid cell activation involved in immune response (GO:0002275) | 2.41163175 |
98 | mature B cell differentiation (GO:0002335) | 2.40334937 |
99 | regulation of regulated secretory pathway (GO:1903305) | 2.39604706 |
100 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.39363550 |
101 | response to interferon-alpha (GO:0035455) | 2.39307066 |
102 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.38705355 |
103 | dendritic cell differentiation (GO:0097028) | 2.38542272 |
104 | viral transcription (GO:0019083) | 2.38353936 |
105 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.38194092 |
106 | positive regulation of chemokine secretion (GO:0090197) | 2.37977917 |
107 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.37315698 |
108 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.36941487 |
109 | negative regulation of innate immune response (GO:0045824) | 2.36372180 |
110 | myeloid dendritic cell activation (GO:0001773) | 2.35848110 |
111 | myeloid dendritic cell differentiation (GO:0043011) | 2.35705120 |
112 | cellular response to zinc ion (GO:0071294) | 2.34817562 |
113 | plasma lipoprotein particle assembly (GO:0034377) | 2.34804812 |
114 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.34475163 |
115 | response to host immune response (GO:0052572) | 2.34475163 |
116 | folic acid transport (GO:0015884) | 2.34235697 |
117 | leukocyte mediated cytotoxicity (GO:0001909) | 2.33766461 |
118 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.32851567 |
119 | positive thymic T cell selection (GO:0045059) | 2.32333593 |
120 | translational termination (GO:0006415) | 2.31451818 |
121 | regulation of T cell tolerance induction (GO:0002664) | 2.30367927 |
122 | B cell receptor signaling pathway (GO:0050853) | 2.29835291 |
123 | T cell apoptotic process (GO:0070231) | 2.29731107 |
124 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.28876446 |
125 | positive regulation of B cell mediated immunity (GO:0002714) | 2.28876446 |
126 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.28628344 |
127 | apoptotic cell clearance (GO:0043277) | 2.28347549 |
128 | negative regulation of T cell mediated immunity (GO:0002710) | 2.28058152 |
129 | defense response to protozoan (GO:0042832) | 2.26359576 |
130 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.26119778 |
131 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.25314133 |
132 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.25284943 |
133 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.25093805 |
134 | glycosylceramide metabolic process (GO:0006677) | 2.24469938 |
135 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.24320031 |
136 | regulation of interferon-beta production (GO:0032648) | 2.22589188 |
137 | response to protozoan (GO:0001562) | 2.22263150 |
138 | cellular extravasation (GO:0045123) | 2.21682149 |
139 | formation of translation preinitiation complex (GO:0001731) | 2.21311237 |
140 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.21257458 |
141 | regulation of antigen processing and presentation (GO:0002577) | 2.20676570 |
142 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.20385544 |
143 | regulation of cholesterol storage (GO:0010885) | 2.20237440 |
144 | neutrophil activation (GO:0042119) | 2.18877316 |
145 | nucleobase biosynthetic process (GO:0046112) | 2.18752132 |
146 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.18434377 |
147 | positive regulation of lamellipodium assembly (GO:0010592) | 2.18299461 |
148 | hyaluronan catabolic process (GO:0030214) | 2.17834574 |
149 | mature B cell differentiation involved in immune response (GO:0002313) | 2.17301273 |
150 | purine-containing compound salvage (GO:0043101) | 2.17132229 |
151 | negative regulation of growth of symbiont in host (GO:0044130) | 2.16221796 |
152 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.16221796 |
153 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.16221796 |
154 | regulation of growth of symbiont in host (GO:0044126) | 2.16221796 |
155 | response to type I interferon (GO:0034340) | 2.16213027 |
156 | cellular response to type I interferon (GO:0071357) | 2.16108539 |
157 | type I interferon signaling pathway (GO:0060337) | 2.16108539 |
158 | regulation of protein heterodimerization activity (GO:0043497) | 2.15725622 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.29196573 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.16409216 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.15677482 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.09752208 |
5 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54862636 |
6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.51377364 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.43599216 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40295478 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33887962 |
10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.32047004 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.30597633 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30439933 |
13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28847946 |
14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28122634 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 2.23554321 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09387191 |
17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.05177846 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04599590 |
19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.01164247 |
20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01159634 |
21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00538336 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94716830 |
23 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93956801 |
24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86612167 |
25 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82633050 |
26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81382885 |
27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79733835 |
28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79296581 |
29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.78234219 |
30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76525516 |
31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74145789 |
32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.72246636 |
33 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.70911401 |
34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.70297966 |
35 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.68160447 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66409609 |
37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65741932 |
38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64421667 |
39 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.64087604 |
40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63982573 |
41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63234311 |
42 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.62344963 |
43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59125329 |
44 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.58191404 |
45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.58056775 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56325462 |
47 | MAF_26560356_Chip-Seq_TH1_Human | 1.54068349 |
48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54059407 |
49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53416164 |
50 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.52124372 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50141915 |
52 | P68_20966046_ChIP-Seq_HELA_Human | 1.49999845 |
53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49608245 |
54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.48420462 |
55 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.48092107 |
56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47167216 |
57 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.44417098 |
58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42606031 |
59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42033142 |
60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38159589 |
61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37202331 |
62 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36213730 |
63 | MYB_26560356_Chip-Seq_TH2_Human | 1.36194216 |
64 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.34727479 |
65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34462955 |
66 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34148996 |
67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34112186 |
68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33935788 |
69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.33450434 |
70 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.33201806 |
71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32945218 |
72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31887119 |
73 | MYB_26560356_Chip-Seq_TH1_Human | 1.29985263 |
74 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.29815610 |
75 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.29533026 |
76 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29290456 |
77 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29232721 |
78 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.29011144 |
79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28967060 |
80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27453351 |
81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26877163 |
82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26805505 |
83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26269132 |
84 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25560095 |
85 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25106790 |
86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24539470 |
87 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.24362730 |
88 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24018965 |
89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23764576 |
90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23637698 |
91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22245152 |
92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21508124 |
93 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.20078518 |
94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20024427 |
95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19730896 |
96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19591424 |
97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19543834 |
98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19276155 |
99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18474288 |
100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.18464453 |
101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18320183 |
102 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.17995442 |
103 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.17536299 |
104 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17533817 |
105 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.16561037 |
106 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16228894 |
107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15549201 |
108 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14695148 |
109 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13986841 |
110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13947106 |
111 | MAF_26560356_Chip-Seq_TH2_Human | 1.13042852 |
112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13017456 |
113 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12439824 |
114 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11903981 |
115 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09966194 |
116 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09125119 |
117 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08369064 |
118 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06818745 |
119 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06416781 |
120 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06383098 |
121 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06172423 |
122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05737133 |
123 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05463171 |
124 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05118583 |
125 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05054401 |
126 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04275126 |
127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03106561 |
128 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02889472 |
129 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02767729 |
130 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02665253 |
131 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01197423 |
132 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.01175639 |
133 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00781633 |
134 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00547514 |
135 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00097607 |
136 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97158627 |
137 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96860013 |
138 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96501788 |
139 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96117722 |
140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96105099 |
141 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95931351 |
142 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95127375 |
143 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94472998 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009840_abnormal_foam_cell | 3.30839229 |
2 | MP0005058_abnormal_lysosome_morphology | 3.23722214 |
3 | MP0001835_abnormal_antigen_presentation | 3.17082748 |
4 | MP0003436_decreased_susceptibility_to | 3.07702258 |
5 | MP0003303_peritoneal_inflammation | 2.62279280 |
6 | MP0003191_abnormal_cellular_cholesterol | 2.48623169 |
7 | MP0002419_abnormal_innate_immunity | 2.41735722 |
8 | MP0009785_altered_susceptibility_to | 2.24446532 |
9 | MP0005000_abnormal_immune_tolerance | 2.21100121 |
10 | MP0005025_abnormal_response_to | 2.19588532 |
11 | MP0006082_CNS_inflammation | 2.17419417 |
12 | MP0000685_abnormal_immune_system | 2.15643094 |
13 | MP0002396_abnormal_hematopoietic_system | 2.14636013 |
14 | MP0002452_abnormal_antigen_presenting | 2.11896218 |
15 | MP0001800_abnormal_humoral_immune | 2.08998747 |
16 | MP0005464_abnormal_platelet_physiology | 2.07516495 |
17 | MP0003724_increased_susceptibility_to | 2.01139312 |
18 | MP0002148_abnormal_hypersensitivity_rea | 1.99502268 |
19 | MP0002723_abnormal_immune_serum | 1.95459406 |
20 | MP0005671_abnormal_response_to | 1.94225224 |
21 | MP0009333_abnormal_splenocyte_physiolog | 1.89729763 |
22 | MP0005387_immune_system_phenotype | 1.89370206 |
23 | MP0001790_abnormal_immune_system | 1.89370206 |
24 | MP0002420_abnormal_adaptive_immunity | 1.86122531 |
25 | MP0001819_abnormal_immune_cell | 1.85960484 |
26 | MP0001853_heart_inflammation | 1.78138436 |
27 | MP0003693_abnormal_embryo_hatching | 1.77218004 |
28 | MP0003195_calcinosis | 1.74212993 |
29 | MP0005167_abnormal_blood-brain_barrier | 1.68097186 |
30 | * MP0003172_abnormal_lysosome_physiology | 1.67567715 |
31 | MP0005397_hematopoietic_system_phenotyp | 1.67549124 |
32 | MP0001545_abnormal_hematopoietic_system | 1.67549124 |
33 | MP0001533_abnormal_skeleton_physiology | 1.66948335 |
34 | MP0002405_respiratory_system_inflammati | 1.66562710 |
35 | MP0000689_abnormal_spleen_morphology | 1.65326099 |
36 | MP0002398_abnormal_bone_marrow | 1.64131852 |
37 | MP0001845_abnormal_inflammatory_respons | 1.59734710 |
38 | MP0000716_abnormal_immune_system | 1.59062039 |
39 | MP0003300_gastrointestinal_ulcer | 1.58940892 |
40 | MP0008469_abnormal_protein_level | 1.55080387 |
41 | MP0002722_abnormal_immune_system | 1.53677181 |
42 | MP0004947_skin_inflammation | 1.50878450 |
43 | MP0000465_gastrointestinal_hemorrhage | 1.50705167 |
44 | MP0010155_abnormal_intestine_physiology | 1.50623812 |
45 | MP0000490_abnormal_crypts_of | 1.46980619 |
46 | MP0002166_altered_tumor_susceptibility | 1.45787228 |
47 | MP0002429_abnormal_blood_cell | 1.45071608 |
48 | MP0004510_myositis | 1.43138119 |
49 | MP0010307_abnormal_tumor_latency | 1.42904755 |
50 | MP0000343_altered_response_to | 1.41305568 |
51 | MP0008260_abnormal_autophagy | 1.35504034 |
52 | MP0003763_abnormal_thymus_physiology | 1.35028073 |
53 | MP0003705_abnormal_hypodermis_morpholog | 1.32378321 |
54 | MP0009278_abnormal_bone_marrow | 1.31341537 |
55 | MP0000858_altered_metastatic_potential | 1.30944948 |
56 | MP0004808_abnormal_hematopoietic_stem | 1.27054959 |
57 | MP0003656_abnormal_erythrocyte_physiolo | 1.26906634 |
58 | MP0003806_abnormal_nucleotide_metabolis | 1.25811389 |
59 | MP0001873_stomach_inflammation | 1.25038068 |
60 | MP0003329_amyloid_beta_deposits | 1.23933059 |
61 | MP0000015_abnormal_ear_pigmentation | 1.22505329 |
62 | MP0010352_gastrointestinal_tract_polyps | 1.22035423 |
63 | MP0003186_abnormal_redox_activity | 1.20422756 |
64 | MP0003690_abnormal_glial_cell | 1.20238521 |
65 | MP0002138_abnormal_hepatobiliary_system | 1.20057038 |
66 | MP0003566_abnormal_cell_adhesion | 1.19577693 |
67 | MP0005451_abnormal_body_composition | 1.18578839 |
68 | MP0003448_altered_tumor_morphology | 1.14688122 |
69 | MP0000609_abnormal_liver_physiology | 1.12459808 |
70 | MP0002006_tumorigenesis | 1.11783236 |
71 | MP0005360_urolithiasis | 1.09703986 |
72 | MP0004957_abnormal_blastocyst_morpholog | 1.09472974 |
73 | MP0009764_decreased_sensitivity_to | 1.07843766 |
74 | MP0003111_abnormal_nucleus_morphology | 1.05600384 |
75 | MP0001986_abnormal_taste_sensitivity | 1.05486994 |
76 | MP0005023_abnormal_wound_healing | 1.01956644 |
77 | MP0008438_abnormal_cutaneous_collagen | 1.01554371 |
78 | MP0003075_altered_response_to | 1.01387907 |
79 | MP0009763_increased_sensitivity_to | 1.00333165 |
80 | MP0002254_reproductive_system_inflammat | 1.00286151 |
81 | MP0005319_abnormal_enzyme/_coenzyme | 0.99752331 |
82 | MP0000604_amyloidosis | 0.99358019 |
83 | MP0006054_spinal_hemorrhage | 0.99203216 |
84 | MP0003879_abnormal_hair_cell | 0.98411069 |
85 | MP0000920_abnormal_myelination | 0.96674766 |
86 | MP0003077_abnormal_cell_cycle | 0.96633294 |
87 | MP0002933_joint_inflammation | 0.96236543 |
88 | MP0000598_abnormal_liver_morphology | 0.95981339 |
89 | MP0002019_abnormal_tumor_incidence | 0.95303341 |
90 | MP0000703_abnormal_thymus_morphology | 0.95278266 |
91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.92522176 |
92 | MP0002139_abnormal_hepatobiliary_system | 0.91954851 |
93 | MP0000371_diluted_coat_color | 0.91260293 |
94 | MP0005075_abnormal_melanosome_morpholog | 0.90920043 |
95 | MP0010094_abnormal_chromosome_stability | 0.89891461 |
96 | MP0005365_abnormal_bile_salt | 0.89880736 |
97 | MP0001501_abnormal_sleep_pattern | 0.86103846 |
98 | MP0001764_abnormal_homeostasis | 0.85740525 |
99 | MP0005647_abnormal_sex_gland | 0.85730568 |
100 | MP0003866_abnormal_defecation | 0.85605925 |
101 | MP0010329_abnormal_lipoprotein_level | 0.85250730 |
102 | MP0008007_abnormal_cellular_replicative | 0.84058475 |
103 | MP0005174_abnormal_tail_pigmentation | 0.83479198 |
104 | MP0005310_abnormal_salivary_gland | 0.82893896 |
105 | MP0005166_decreased_susceptibility_to | 0.82823660 |
106 | MP0003633_abnormal_nervous_system | 0.82053965 |
107 | MP0002693_abnormal_pancreas_physiology | 0.81589826 |
108 | MP0002118_abnormal_lipid_homeostasis | 0.81351947 |
109 | MP0001968_abnormal_touch/_nociception | 0.81156083 |
110 | MP0001851_eye_inflammation | 0.80727683 |
111 | MP0002998_abnormal_bone_remodeling | 0.79707176 |
112 | MP0003183_abnormal_peptide_metabolism | 0.79279772 |
113 | MP0005165_increased_susceptibility_to | 0.78274183 |
114 | MP0005076_abnormal_cell_differentiation | 0.78099663 |
115 | MP0002653_abnormal_ependyma_morphology | 0.78094934 |
116 | MP0005390_skeleton_phenotype | 0.77915258 |
117 | MP0009643_abnormal_urine_homeostasis | 0.77900102 |
118 | MP0008873_increased_physiological_sensi | 0.77808562 |
119 | MP0005670_abnormal_white_adipose | 0.77542257 |
120 | MP0001663_abnormal_digestive_system | 0.75967731 |
121 | MP0002064_seizures | 0.75617073 |
122 | MP0000249_abnormal_blood_vessel | 0.74583969 |
123 | MP0001915_intracranial_hemorrhage | 0.74028764 |
124 | MP0000313_abnormal_cell_death | 0.73195054 |
125 | MP0003828_pulmonary_edema | 0.72068712 |
126 | MP0008874_decreased_physiological_sensi | 0.69661971 |
127 | MP0008004_abnormal_stomach_pH | 0.66492241 |
128 | MP0005164_abnormal_response_to | 0.61967706 |
129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61729474 |
130 | MP0003795_abnormal_bone_structure | 0.57724622 |
131 | MP0009642_abnormal_blood_homeostasis | 0.55097497 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.70741161 |
2 | Eczematoid dermatitis (HP:0000976) | 4.44048618 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.28094787 |
4 | Systemic lupus erythematosus (HP:0002725) | 4.14301366 |
5 | Vacuolated lymphocytes (HP:0001922) | 4.07024042 |
6 | Dysostosis multiplex (HP:0000943) | 3.82875541 |
7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.75869372 |
8 | Abnormality of macrophages (HP:0004311) | 3.65818879 |
9 | Stomatitis (HP:0010280) | 3.65723022 |
10 | IgM deficiency (HP:0002850) | 3.51013910 |
11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.42577854 |
12 | Increased cerebral lipofuscin (HP:0011813) | 3.42491485 |
13 | Thrombocytosis (HP:0001894) | 3.23098150 |
14 | Mutism (HP:0002300) | 3.21488173 |
15 | Purpura (HP:0000979) | 3.15453205 |
16 | Chronic otitis media (HP:0000389) | 3.14169797 |
17 | Glomerulonephritis (HP:0000099) | 3.07488316 |
18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.06863242 |
19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03320662 |
20 | Mucopolysacchariduria (HP:0008155) | 3.03320662 |
21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96290217 |
22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96290217 |
23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96290217 |
24 | Recurrent skin infections (HP:0001581) | 2.94134924 |
25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.89694361 |
26 | Amyloidosis (HP:0011034) | 2.88013465 |
27 | Myositis (HP:0100614) | 2.85348391 |
28 | Petechiae (HP:0000967) | 2.85062878 |
29 | Retrobulbar optic neuritis (HP:0100654) | 2.83478944 |
30 | Optic neuritis (HP:0100653) | 2.83478944 |
31 | Recurrent fungal infections (HP:0002841) | 2.80663495 |
32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.75550246 |
33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.75550246 |
34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.75550246 |
35 | Recurrent viral infections (HP:0004429) | 2.73953465 |
36 | Pustule (HP:0200039) | 2.69429808 |
37 | Cellulitis (HP:0100658) | 2.65885836 |
38 | Axonal loss (HP:0003447) | 2.62707288 |
39 | Abnormality of complement system (HP:0005339) | 2.59984898 |
40 | Agnosia (HP:0010524) | 2.58697649 |
41 | Mediastinal lymphadenopathy (HP:0100721) | 2.58135599 |
42 | Periodontitis (HP:0000704) | 2.55235537 |
43 | Complement deficiency (HP:0004431) | 2.53825505 |
44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53530389 |
45 | Obstructive lung disease (HP:0006536) | 2.53530389 |
46 | Pulmonary infiltrates (HP:0002113) | 2.47344137 |
47 | Autoimmune thrombocytopenia (HP:0001973) | 2.44586478 |
48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.40263514 |
49 | Loss of speech (HP:0002371) | 2.40010740 |
50 | Epistaxis (HP:0000421) | 2.39233597 |
51 | Interstitial pulmonary disease (HP:0006530) | 2.36007684 |
52 | Increased serum ferritin (HP:0003281) | 2.35654684 |
53 | Abnormality of T cell physiology (HP:0011840) | 2.33806054 |
54 | Neuronal loss in central nervous system (HP:0002529) | 2.33267119 |
55 | Prolonged neonatal jaundice (HP:0006579) | 2.32900287 |
56 | Spontaneous hematomas (HP:0007420) | 2.30071070 |
57 | Abnormal platelet function (HP:0011869) | 2.27174376 |
58 | Impaired platelet aggregation (HP:0003540) | 2.27174376 |
59 | Episodic fever (HP:0001954) | 2.24727998 |
60 | Abnormality of the nasal mucosa (HP:0000433) | 2.24662349 |
61 | Gastrointestinal inflammation (HP:0004386) | 2.23444336 |
62 | Myocardial infarction (HP:0001658) | 2.23015817 |
63 | Colitis (HP:0002583) | 2.22438966 |
64 | Reduced antithrombin III activity (HP:0001976) | 2.21663434 |
65 | Albinism (HP:0001022) | 2.21258544 |
66 | Inflammation of the large intestine (HP:0002037) | 2.21093287 |
67 | Nasal polyposis (HP:0100582) | 2.20711453 |
68 | Hepatosplenomegaly (HP:0001433) | 2.19187535 |
69 | Thoracic kyphosis (HP:0002942) | 2.18207633 |
70 | Keratoconjunctivitis (HP:0001096) | 2.16602068 |
71 | Keratoconjunctivitis sicca (HP:0001097) | 2.16529069 |
72 | Global brain atrophy (HP:0002283) | 2.14981590 |
73 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.14570638 |
74 | Urticaria (HP:0001025) | 2.13495529 |
75 | Diminished motivation (HP:0000745) | 2.13210126 |
76 | Gingivitis (HP:0000230) | 2.13176157 |
77 | Neurofibrillary tangles (HP:0002185) | 2.12603382 |
78 | Disinhibition (HP:0000734) | 2.12589777 |
79 | Osteolytic defects of the hand bones (HP:0009699) | 2.12271824 |
80 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.12271824 |
81 | Meningitis (HP:0001287) | 2.11489578 |
82 | Apathy (HP:0000741) | 2.11444086 |
83 | Hemoptysis (HP:0002105) | 2.10462014 |
84 | Abnormality of iron homeostasis (HP:0011031) | 2.05417882 |
85 | Gingival bleeding (HP:0000225) | 2.05405636 |
86 | Recurrent bronchitis (HP:0002837) | 2.04982596 |
87 | Prolonged bleeding time (HP:0003010) | 2.04483006 |
88 | Abnormal number of erythroid precursors (HP:0012131) | 2.04403669 |
89 | Metaphyseal irregularity (HP:0003025) | 2.02903234 |
90 | Asymmetric septal hypertrophy (HP:0001670) | 2.01901015 |
91 | Basal ganglia calcification (HP:0002135) | 2.01492307 |
92 | Personality changes (HP:0000751) | 2.00464511 |
93 | Poor head control (HP:0002421) | 2.00278631 |
94 | Hematochezia (HP:0002573) | 1.99208345 |
95 | Deep venous thrombosis (HP:0002625) | 1.98793212 |
96 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.97646540 |
97 | Xanthomatosis (HP:0000991) | 1.97560246 |
98 | Vasculitis (HP:0002633) | 1.97020466 |
99 | Visual hallucinations (HP:0002367) | 1.96979923 |
100 | Leukocytosis (HP:0001974) | 1.96082121 |
101 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95901527 |
102 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95901527 |
103 | Joint stiffness (HP:0001387) | 1.95713933 |
104 | Joint hemorrhage (HP:0005261) | 1.92931441 |
105 | Dementia (HP:0000726) | 1.92816007 |
106 | Supranuclear gaze palsy (HP:0000605) | 1.92517823 |
107 | Abnormality of the periventricular white matter (HP:0002518) | 1.91957055 |
108 | Abnormality of T cells (HP:0002843) | 1.90423911 |
109 | Osteomyelitis (HP:0002754) | 1.90262570 |
110 | Retinal atrophy (HP:0001105) | 1.89621770 |
111 | Conjunctival telangiectasia (HP:0000524) | 1.89606439 |
112 | Granulocytopenia (HP:0001913) | 1.89184204 |
113 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89053704 |
114 | Progressive neurologic deterioration (HP:0002344) | 1.89038122 |
115 | Pathologic fracture (HP:0002756) | 1.89001263 |
116 | Nausea (HP:0002018) | 1.88513705 |
117 | Panhypogammaglobulinemia (HP:0003139) | 1.88178123 |
118 | Increased IgM level (HP:0003496) | 1.88172191 |
119 | Orchitis (HP:0100796) | 1.87799273 |
120 | J-shaped sella turcica (HP:0002680) | 1.87484805 |
121 | Mesangial abnormality (HP:0001966) | 1.86667406 |
122 | Nephritis (HP:0000123) | 1.85115679 |
123 | Nonimmune hydrops fetalis (HP:0001790) | 1.85043193 |
124 | Progressive visual loss (HP:0000529) | 1.83415717 |
125 | Cervical subluxation (HP:0003308) | 1.82936489 |
126 | Upper motor neuron abnormality (HP:0002127) | 1.82838850 |
127 | Eosinophilia (HP:0001880) | 1.82145298 |
128 | Abnormality of the thoracic spine (HP:0100711) | 1.81791881 |
129 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.81481111 |
130 | Vertebral compression fractures (HP:0002953) | 1.80595897 |
131 | Encephalitis (HP:0002383) | 1.79126907 |
132 | Hemorrhage of the eye (HP:0011885) | 1.79060769 |
133 | Polyneuropathy (HP:0001271) | 1.77452254 |
134 | Chest pain (HP:0100749) | 1.75551419 |
135 | Abnormality of the pleura (HP:0002103) | 1.75211026 |
136 | Nuclear cataract (HP:0100018) | 1.72206006 |
137 | Progressive microcephaly (HP:0000253) | 1.70188151 |
138 | Memory impairment (HP:0002354) | 1.69428558 |
139 | Ocular albinism (HP:0001107) | 1.68251516 |
140 | Pulmonary embolism (HP:0002204) | 1.67184106 |
141 | Abnormality of lateral ventricle (HP:0030047) | 1.66872329 |
142 | Gastrointestinal infarctions (HP:0005244) | 1.66506898 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.61547851 |
2 | ERN1 | 3.29658485 |
3 | BLK | 2.87744918 |
4 | TBK1 | 2.30816443 |
5 | KDR | 2.24434346 |
6 | NME2 | 2.23522143 |
7 | TYK2 | 2.22281777 |
8 | TGFBR2 | 2.22167754 |
9 | IRAK4 | 2.21840025 |
10 | PKN2 | 2.21479195 |
11 | KIT | 2.20404428 |
12 | TRIB3 | 2.15028526 |
13 | SCYL2 | 2.08022984 |
14 | IRAK3 | 2.04694284 |
15 | TESK2 | 1.97233743 |
16 | ZAP70 | 1.90665905 |
17 | CSF1R | 1.87622692 |
18 | STK10 | 1.85726873 |
19 | PIM2 | 1.77517087 |
20 | MAP2K3 | 1.75632758 |
21 | DAPK2 | 1.73410535 |
22 | FLT3 | 1.73295147 |
23 | WEE1 | 1.67494967 |
24 | BTK | 1.66467693 |
25 | RPS6KA4 | 1.66358541 |
26 | MAP3K13 | 1.62285258 |
27 | TIE1 | 1.61357159 |
28 | EEF2K | 1.60802858 |
29 | JAK3 | 1.53325532 |
30 | PRPF4B | 1.53129742 |
31 | BCKDK | 1.51702063 |
32 | EIF2AK1 | 1.50796269 |
33 | TNK2 | 1.43082007 |
34 | NEK2 | 1.41976909 |
35 | LRRK2 | 1.41607361 |
36 | TEC | 1.40979236 |
37 | MAP3K11 | 1.39525041 |
38 | SIK2 | 1.39300451 |
39 | GRK7 | 1.38752318 |
40 | PAK4 | 1.37316500 |
41 | ADRBK2 | 1.35646173 |
42 | FRK | 1.34611194 |
43 | BUB1 | 1.32430223 |
44 | EIF2AK3 | 1.31817536 |
45 | MAP3K10 | 1.30628266 |
46 | TAOK2 | 1.29703775 |
47 | FGR | 1.21726077 |
48 | PRKD2 | 1.17536457 |
49 | IKBKE | 1.16219713 |
50 | SYK | 1.14641703 |
51 | MAP2K6 | 1.14401292 |
52 | STK16 | 1.13371894 |
53 | RIPK4 | 1.10738962 |
54 | IKBKB | 1.10101524 |
55 | ACVR1B | 1.07479352 |
56 | TAOK3 | 1.04115967 |
57 | TSSK6 | 0.98959684 |
58 | PIM1 | 0.98193712 |
59 | CSK | 0.98091889 |
60 | PDPK1 | 0.97801289 |
61 | GRK1 | 0.97645495 |
62 | TTN | 0.97524342 |
63 | MAP3K8 | 0.95505968 |
64 | CDC42BPA | 0.93027152 |
65 | DAPK1 | 0.92261712 |
66 | MAP3K3 | 0.92132784 |
67 | PDK1 | 0.90960937 |
68 | LYN | 0.89903342 |
69 | MAP3K1 | 0.89270539 |
70 | GRK6 | 0.88713569 |
71 | MAP3K14 | 0.88440625 |
72 | HCK | 0.87084721 |
73 | LCK | 0.86075514 |
74 | JAK1 | 0.83520129 |
75 | PASK | 0.82884219 |
76 | SIK3 | 0.81393611 |
77 | RPS6KB2 | 0.81104367 |
78 | PAK6 | 0.80942220 |
79 | CDK4 | 0.80207039 |
80 | ITK | 0.79298869 |
81 | MAPKAPK3 | 0.78546130 |
82 | TXK | 0.77644609 |
83 | BMPR2 | 0.77469501 |
84 | CAMKK2 | 0.76363450 |
85 | MATK | 0.75906535 |
86 | ABL2 | 0.74052992 |
87 | EPHA2 | 0.72766411 |
88 | JAK2 | 0.72023350 |
89 | FES | 0.71894091 |
90 | SIK1 | 0.71847772 |
91 | TGFBR1 | 0.71320069 |
92 | EPHB1 | 0.71005921 |
93 | MAPK12 | 0.69672000 |
94 | CDK7 | 0.64831500 |
95 | TESK1 | 0.63938977 |
96 | NEK9 | 0.63333718 |
97 | CLK1 | 0.62154990 |
98 | MAP2K2 | 0.61853659 |
99 | CDC7 | 0.59565609 |
100 | FGFR4 | 0.59094326 |
101 | MARK2 | 0.58489718 |
102 | CAMK1D | 0.58343653 |
103 | STK4 | 0.57649452 |
104 | PRKG2 | 0.56245216 |
105 | IRAK2 | 0.55773936 |
106 | STK38 | 0.55258875 |
107 | CDK12 | 0.53222742 |
108 | MAPK4 | 0.52959626 |
109 | RPS6KA2 | 0.52432214 |
110 | PTK6 | 0.51120394 |
111 | PRKCQ | 0.49928215 |
112 | CAMKK1 | 0.49920822 |
113 | BRSK2 | 0.49335072 |
114 | MARK3 | 0.48800345 |
115 | CHUK | 0.48291934 |
116 | TLK1 | 0.46271201 |
117 | BMX | 0.45548611 |
118 | FGFR3 | 0.45478368 |
119 | NTRK3 | 0.45382542 |
120 | CAMK4 | 0.45049898 |
121 | PTK2B | 0.45000626 |
122 | CDK6 | 0.44151403 |
123 | MAPK11 | 0.44010740 |
124 | ICK | 0.43574668 |
125 | TYRO3 | 0.43383012 |
126 | VRK1 | 0.42263576 |
127 | MAPKAPK2 | 0.42008070 |
128 | MAP4K2 | 0.40966652 |
129 | DYRK3 | 0.40110209 |
130 | ATR | 0.40029763 |
131 | HIPK2 | 0.39368520 |
132 | PAK1 | 0.39214688 |
133 | ARAF | 0.38506828 |
134 | RPS6KA6 | 0.37864464 |
135 | MOS | 0.37694212 |
136 | PINK1 | 0.37588125 |
137 | DAPK3 | 0.37306077 |
138 | PRKAA2 | 0.37210032 |
139 | RPS6KC1 | 0.37178972 |
140 | RPS6KL1 | 0.37178972 |
141 | MAP3K5 | 0.37151812 |
142 | ABL1 | 0.37062435 |
143 | DDR2 | 0.36374407 |
144 | NLK | 0.32792643 |
145 | EIF2AK2 | 0.31674631 |
146 | TAOK1 | 0.31412682 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.84825517 |
2 | DNA replication_Homo sapiens_hsa03030 | 2.72897895 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 2.57194737 |
4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.49214793 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.43190162 |
6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.28249924 |
7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.20893148 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.19019583 |
9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.18945787 |
10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13537220 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.12185170 |
12 | * Lysosome_Homo sapiens_hsa04142 | 2.00402428 |
13 | Ribosome_Homo sapiens_hsa03010 | 1.90188335 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89652689 |
15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.79618810 |
16 | Legionellosis_Homo sapiens_hsa05134 | 1.74502737 |
17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69516486 |
18 | Proteasome_Homo sapiens_hsa03050 | 1.67865554 |
19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.67214449 |
20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.65238408 |
21 | Mismatch repair_Homo sapiens_hsa03430 | 1.59218512 |
22 | Base excision repair_Homo sapiens_hsa03410 | 1.57889983 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56443745 |
24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55474156 |
25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49178666 |
26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.48888227 |
27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47409786 |
28 | Pertussis_Homo sapiens_hsa05133 | 1.46433537 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42949558 |
30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41236248 |
31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37865713 |
32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35236236 |
33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34567476 |
34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32872243 |
35 | Measles_Homo sapiens_hsa05162 | 1.32551611 |
36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29413929 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.23733035 |
38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22446797 |
39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21083236 |
40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.20383423 |
41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20311288 |
42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20298278 |
43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15920301 |
44 | Malaria_Homo sapiens_hsa05144 | 1.15688908 |
45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14555709 |
46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12567427 |
47 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.12561179 |
48 | Apoptosis_Homo sapiens_hsa04210 | 1.11627309 |
49 | Shigellosis_Homo sapiens_hsa05131 | 1.08449476 |
50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07735359 |
51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05621222 |
52 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.05576063 |
53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03828287 |
54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01292184 |
55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00844178 |
56 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.00047572 |
57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99756656 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97173809 |
59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94722582 |
60 | Spliceosome_Homo sapiens_hsa03040 | 0.94348297 |
61 | Influenza A_Homo sapiens_hsa05164 | 0.93675114 |
62 | Homologous recombination_Homo sapiens_hsa03440 | 0.93267028 |
63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91238475 |
64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91108179 |
65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.90876140 |
66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87319596 |
67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86041735 |
68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85677767 |
69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85601784 |
70 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82774461 |
71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82766690 |
72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82613807 |
73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.81868223 |
74 | RNA polymerase_Homo sapiens_hsa03020 | 0.80987570 |
75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80761507 |
76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80335975 |
77 | Phagosome_Homo sapiens_hsa04145 | 0.79373504 |
78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77700532 |
79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77597865 |
80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74995952 |
81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74174042 |
82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74111857 |
83 | Salmonella infection_Homo sapiens_hsa05132 | 0.73707347 |
84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73675258 |
85 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72325039 |
86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72152855 |
87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71820417 |
88 | RNA transport_Homo sapiens_hsa03013 | 0.71394136 |
89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71030869 |
90 | Hepatitis B_Homo sapiens_hsa05161 | 0.70506997 |
91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69604599 |
92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68792370 |
93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67520378 |
94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67191137 |
95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65024932 |
96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64081423 |
97 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62451848 |
98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62029279 |
99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59859600 |
100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59010690 |
101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58927131 |
102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57516528 |
103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57321009 |
104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54317567 |
105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52595390 |
106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51859130 |
107 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51520248 |
108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51163185 |
109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50988839 |
110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50931738 |
111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49722680 |
112 | Asthma_Homo sapiens_hsa05310 | 0.49643619 |
113 | Cell cycle_Homo sapiens_hsa04110 | 0.49371225 |
114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48657357 |
115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47787245 |
116 | Mineral absorption_Homo sapiens_hsa04978 | 0.47364663 |
117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46866360 |
118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46313602 |
119 | ABC transporters_Homo sapiens_hsa02010 | 0.44942425 |
120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44284561 |
121 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43938617 |
122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43931075 |
123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43294117 |
124 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42945870 |
125 | Peroxisome_Homo sapiens_hsa04146 | 0.40995509 |
126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40846078 |
127 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40767778 |
128 | Prion diseases_Homo sapiens_hsa05020 | 0.39603061 |
129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38859249 |
130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38771998 |
131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38722488 |
132 | Hepatitis C_Homo sapiens_hsa05160 | 0.38376909 |
133 | Platelet activation_Homo sapiens_hsa04611 | 0.36963456 |
134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35468313 |
135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35083294 |
136 | Endocytosis_Homo sapiens_hsa04144 | 0.34910259 |
137 | Insulin resistance_Homo sapiens_hsa04931 | 0.25950152 |
138 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.24533761 |
139 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24160088 |
140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23464328 |
141 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23215060 |
142 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19778767 |